Trump’s Re-Election Sparks Stock Movements: Key Winners and Losers for Investors
Tech, Energy, and Industrial Stocks to Watch as Trump’s Policies Shape Market Sentiment With Donald J. Trump re-elected as the ...
Tag: News
Super Micro Computer Reports Preliminary Q1 Financials and Concludes Independent Investigation
Company Misses Revenue Guidance but Strengthens Governance After Special Committee Review Super Micro Computer (SMCI), a leading provider of IT ...
e.l.f. Beauty Defies Industry Slowdown with Strong Second-Quarter Sales Growth
Affordable Cosmetics Strategy Helps e.l.f. Gain Market Share Amid Weak Demand for Premium Brands e.l.f. Beauty (ELF) is projected to ...
Trump Media Stock Soars on Election Speculation, But Volatility Looms
Shares of DJT Recover from Steep Decline, Driven by Election Sentiment and Meme-Stock Dynamics Trump Media & Technology Group (DJT) ...
BioMarin Pharmaceuticals’ New Strategy Promises Strong Upside, Led by Voxzogo and Roctavian
Wedbush Sees Favorable Risk/Reward as BioMarin Targets Growth in Rare Disease Market BioMarin Pharmaceuticals (BMRN), a leader in rare disease ...
Palantir Technologies Raises Annual Forecast Amid Rising Demand for AI and Government Services
With Record Profits and Strong U.S. Government Spending, Palantir Solidifies Its Position as an AI Powerhouse Palantir Technologies (PLTR) announced ...
Marathon Digital Holdings Sees Record Bitcoin Production in October 2024
With Energized Hash Rate and Strategic Innovations, MARA Sets Sights on 50 EH/s Target Marathon Digital Holdings (MARA), a prominent ...
Why Investors Should Keep An Eye On Alibaba Holdings For Long-Term Gains
Despite Market Fluctuations, Alibaba’s Strategic Positioning and Growth Potential Make it a Compelling Investment Choice In the realm of Chinese ...
NVIDIA and Sherwin-Williams Join the Dow Jones Industrial Average in Major Index Shake-Up
Intel and Dow Inc. Make Way for Sector Realignment, While Vistra Replaces AES in the Dow Jones Utility Average The ...
Viking Therapeutics’ VK2735 Demonstrates Promising Weight Loss Results in Phase 1 and Phase 2 Trials
Clinical Data from Oral and Subcutaneous Doses Show Effective Weight Loss and Support Potential for Long-Term Dosing Strategies Viking Therapeutics ...
